Enterprise Value
319M
Cash
262.9M
Avg Qtr Burn
-22.62M
Short % of Float
13.46%
Insider Ownership
28.15%
Institutional Own.
42.18%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
COMP360 (Psilocybin) Details Treatment Resistant Depression | Phase 3 Data readout | |
COMP360 (Psilocybin) Details Post-traumatic stress disorder | Phase 2 Update | |
COMP360 (Psilocybin) Details Anorexia nervosa | Phase 2 Update |